The geneMAP™ HER2 Expression Analysis Kit leverages multiplex real-time PCR technology and TaqMan Probe technology for the precise and efficient analysis of HER2 (human epidermal growth factor receptor 2) gene expression. This research-use-only (RUO) kit is compatible with FAM and VIC/HEX two-color real-time PCR instruments. HER2 plays a vital role in the diagnosis and treatment of breast cancer, with approximately 20-30% of patients exhibiting HER2 overexpression associated with poor prognosis. This kit enables the quantitative evaluation of HER2 messenger RNA (mRNA) levels in formalin-fixed paraffin-embedded (FFPE) tissue samples, providing essential data for research into breast cancer diagnostics and therapeutics.
- Multiplex Real-time PCR Technology: Enables fast and efficient HER2 expression analysis.
- TaqMan Probe Technology: Ensures accurate quantification of HER2 mRNA levels.
- Instrument Compatibility: Optimized for use with FAM and VIC/HEX two-color real-time PCR instruments, offering flexibility for laboratory applications.
- Enhanced Diagnostic Research: Provides a valuable tool for studying HER2 gene expression in breast cancer, aiding in the identification of patients with poor prognosis.
- Accurate and Reliable: Delivers precise quantification of HER2 mRNA, critical for advancing breast cancer research and potential treatment strategies.
- Rapid and User-Friendly: Simplifies the process of gene expression analysis, allowing for quick and efficient experimentation.
- Breast Cancer Research: Essential for the investigation of HER2 overexpression in breast cancer patients, contributing to the development of diagnostic and therapeutic approaches.
- Molecular Diagnostic Research: Supports studies focused on the quantitative evaluation of HER2 mRNA levels using RT-qPCR in FFPE tissue samples.
- Technology: Combines multiplex real-time PCR with TaqMan Probe technology for precise gene expression analysis.
- Compatibility: Suitable for use with FAM and VIC/HEX two-color real-time PCR instruments.
- Usage: Intended for research use only, not approved for diagnostic or therapeutic applications.
- Clinical Relevance: Facilitates research into the significance of HER2 expression in breast cancer prognosis and treatment response.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.